Telling Dose Vs Optimizing Dose

#TellingDoseVsOptimizingDose

Morning dose - Till 12 noon

Afternoon - 12 noon to 6pm

Night dose - Before 12 AM

1. That is the unfortunate reality. In India, “dose” is often reduced to instructions like one tablet twice daily, before food or after food. It is treated as a schedule, not as a scientifically individualized quantity.

2.  The deeper meaning of dose—how much exactly this patient needs, based on their physiology, disease state, organ function, and concurrent therapy—is rarely examined.

3. True dose optimization goes far beyond timing. It asks critical questions:

👉 Is the patient’s kidney clearing the drug normally? 

👉 Is the liver metabolizing it efficiently?

👉 Is the body weight appropriate for the standard dose? 

👉 Is the drug reaching therapeutic concentration?

👉 Is the patient elderly, pediatric, critically ill, or on interacting medicines? 

4  Without answering these, giving “one tablet twice daily” becomes a ritual, not rational therapy.

5. Optimization is the science of precision. 

6. Optimization prevents toxicity when the dose is too high and prevents treatment failure when the dose is too low. 

7. Optimization converts prescribing from habit to accountability.

8. In India, timing is emphasized because it is easy to instruct and easy to follow. 

9. Optimization is neglected because it requires measurement, documentation, expertise, and ownership. 

10 Until healthcare formally assigns responsibility for dose optimization—supported by clinical pharmacology services and PharmD professionals—dose will continue to mean frequency, not precision.

11  And that is the difference between giving a medicine and managing drug therapy scientifically.

POV: Bhagwan PS

Does PharmaCare Intervénes With NursingCare

#DoesPharmaCareIntervénesWithNursingCare?

1. No, PharmaCare is the professional responsibility of PharmDs and does not intervene into NursingCare,  it complements it.

2. PharmaCare involves medication reconciliation, therapeutic review, dose optimization, interaction assessment, discharge medication planning, and patient counseling. 

3. These functions require specialized pharmacotherapy knowledge and are the core clinical responsibilities of PharmDs. 

4. This role ensures that every patient receives the most appropriate, safe, and effective medication therapy.

5. NursingCare, on the other hand, focuses on medication administration, bedside monitoring, and observing patient response. 

6. Nurses ensure that medications prescribed and reviewed under PharmaCare are correctly administered and that any clinical changes are promptly reported.

7. Thus, PharmaCare is the clinical domain of PharmDs, and NursingCare is the clinical domain of nurses. Both function collaboratively, not competitively. 

8. PharmaCare ensures medication correctness, and NursingCare ensures medication delivery and monitoring—together ensuring safe, accountable, and high-quality patient care. 

9. This  beings out comete triangular Collaborative support service with the patient in focus.

#MoHFW GoI

#AIPDA 

#APTI

#PharmD

POV: Bhagwan PS

Dose Optimization And Indian Doctors

#DoseOptimizationAndIndianDoctors

1. In India, dose optimization is still not institutionally accepted as a formal, accountable clinical responsibility, even though it is scientifically essential and routinely practiced in advanced healthcare systems. 

2. Prescribing often remains experience-based and generalized, rather than individualized.

3. The same standard dose is given irrespective of patient-specific variables such as age, renal function, liver status, body weight, pharmacogenetic variability, or interacting medicines. 

4. This approach ignores the fundamental principle that the right drug is only safe and effective when given in the right dose for the right patient.

5. The deeper issue is structural, not intellectual. 

6. India’s healthcare system recognizes diagnosis and prescribing authority, but does not formally recognize dose optimization as a defined professional service with legal backing, documentation standards, or accountability frameworks.

 7. Clinical pharmacists, who are trained to optimize dosing through pharmacokinetic and pharmacodynamic assessment, therapeutic drug monitoring, and evidence-based adjustment, are neither empowered nor integrated into routine care. 

8. As a result, dose optimization remains incidental rather than systematic.

9. This gap has consequences. It contributes to adverse drug reactions, therapeutic failure, antimicrobial resistance, prolonged hospital stays, and increased healthcare costs. 

10. Yet these outcomes are rarely traced back to dose appropriateness because dose optimization itself is not formally audited or regulated.

11. Until India formally recognizes dose optimization as a clinical responsibility—supported by law, institutional protocols, and designated professionals such as PharmDs—medication use will remain prescription-centric rather than patient-centric. 

12. True rational drug therapy begins not with selecting the drug alone, but with scientifically optimizing its dose for the individual patient.

#MoHFW GoI

#AIPDA 

#IMA

#APTI

#PharmD

POV: Bhagwan PS

For pharmacy students,. It is an unprecedented opportunity. AI will not replace pharmacists, but pharmacists who use AI will replace those who do not. The future pharmacist will be a combination of clinical expert and digital professional. Those who understand AI will lead healthcare systems, improve patient outcomes, and elevate the profession to new heights.Pharmacy is becoming an intelligent, technology-driven healthcare discipline

#AnIntroductionToAI

 -Dedicated ToPharmacy Students 

For pharmacy students,. It is an unprecedented opportunity. AI will not replace pharmacists, but pharmacists who use AI will replace those who do not. 

The future pharmacist will be a combination of clinical expert and digital professional. 

Those who understand AI will lead healthcare systems, improve patient outcomes, and elevate the profession to new heights.

Pharmacy  is becoming an intelligent, technology-driven healthcare discipline. 

Students who embrace AI today will become the leaders of tomorrow’s pharmacy practice

Now, briefly let us see AI utility sector wise.

Artificial Intelligence is no longer a future concept in pharmacy. It is already influencing every stage of a drug’s life cycle—from manufacture to patient care. 

For pharmacy students, learning AI is becoming essential to remain relevant, effective, and professionally empowered..

I. 1.  In,#DrugLogistics, AI ensures the right medicine is available at the right time and place by analyzing consumption patterns and disease trends, 

2. it predicts demand accurately, prevents shortages, reduces expiry losses, and maintains proper storage conditions, especially for temperature-sensitive medicines.

Ii. 1. In #clincalpractice , AI strengthens patient safety and clinical decision-making.

    2.  It can detect drug interactions, inappropriate doses, and contraindications, and assist in dose adjustment, optimization and medication review. 

  3. This helps pharmacists provide faster, safer, and more Patient - Centered  care.

Iii. 1  In #DrugManufacturing, it helps in  manufacturing layout designing,

      2.  AI helps create efficient, safe, and compliant production facilities.     

     3. By analyzing workflow, equipment placement, material movement, and regulatory requirements, 

    4  AI can design optimal plant layouts that reduce contamination risk, improve productivity, and ensure smooth process flow.

    5. It can simulate different layout models, identify bottlenecks, and recommend improvements before actual construction.

    6.  This saves cost, enhances GMP compliance, and ensures efficient, high-quality drug manufacturing from the very beginning. Prevents sunk investment.

IV. 1. #Production AI improves efficiency, consistency, and quality of formulation, monitors production in real time, predicts equipment failures, reduces waste, and helps optimize formulations. 

  2.  It also accelerates drug development and ensures compliance with quality standards.

V. In #DrugTesting and quality control,   

    1. AI enhances accuracy and reliability.

  2.  It analyzes laboratory data quickly, detects deviations, and predicts drug stability and shelf life.   3.  This ensures only safe and effective medicines reach patients.

VI. 1. In #DrugMarketing, AI enables scientific and need-based distribution.

  2.  It analyzes disease trends and prescribing patterns, helping ensure medicines reach the right regions. 

3.  This improves supply efficiency and supports informed healthcare communication.

4. In retail pharmacy, AI improves dispensing safety and efficiency. 

5.  It checks prescriptions, maintains patient medication records, and helps pharmacists counsel patients better. 

6. Besides it helps in management of inventory,

VII. 1.  It strengthens the pharmacist’s role as a healthcare provider.

     2.  In post-sale services, AI supports ongoing patient care and safety. It helps monitor adverse drug reactions, improve adherence, and evaluate treatment outcomes. Pharmacy care continues beyond dispensing.

3. In drug recall, AI enables rapid identification and withdrawal of defective batches. It tracks distribution instantly, allowing faster recalls and protecting patients. This improves accountability and public safety.

Thus, AI is transforming pharmacy into an intelligent and patient-focused profession. Pharmacy students who learn and use AI will lead the future of healthcare, while those who ignore it risk becoming outdated.

POV: Bhagwan PS

Pharmacist And His Status

#PharmacistAndHisStatus

In India, pharmacy was never positioned as a decision-making profession. 

Doctors were given authority to diagnose and treat; advocates were given authority to argue and represent. Pharmacists were largely confined to dispensing and compliance. 

Authority creates identity, and identity creates respect. When authority is limited, perception also becomes limited.

Education expanded — D.Pharm, B.Pharm, M.Pharm, Pharm.D — but professional identity did not evolve at the same pace. 

Many graduates complete degrees without clarity about their independent responsibility in patient care. 

Without defined clinical territory, policymakers see pharmacists as supportive rather than strategic stakeholders.

Yet the issue is not entirely external.

Pharmacists often divide themselves — retail vs hospital, industry vs clinical, diploma vs degree. Instead of one identity, 

There are comparisons and hierarchies. 

Doctors and advocates may have specializations, but they defend one collective identity as Doctor and Advocate 

Pharmacy has struggled to build that unified professional culture.

Visibility, Doctors appear in public health debates. Advocates shape constitutional discussions. 

Pharmacists, despite being medication experts, rarely occupy policy or media platforms. 

When a profession does not project its value, regulators feel little urgency to expand its role.

There is also the commercial shadow. 

Community pharmacy operates within trade licensing systems, so society often sees the shop before the science. 

When internal compromises occur — proxy attendance, absentee registrations, fee undercutting — credibility weakens further.

Doctors and advocates earned respect not just through knowledge, but through solidarity, legal authority, and assertiveness. 

They protect their professional space collectively.

For pharmacy to command respect, three shifts are essential: 

 i. Internal unity, 

 ii.Clear professional role definition, and 

iii. Visible demonstration of patient impact.

Perhaps the deeper question is not why regulators fail to recognize pharmacists —

but whether pharmacists have fully recognized their own collective strength.

When that recognition becomes firm, external respect will follow.

#CDSCO, #DCD, #PCI #IPA #AIPDA #APTI #Pharmacists

POV: Bhagwan PS

Pharma Career Sans Authority

#PharmaCareerSansAuthority 

There is nothing like Pharma career!

1 A professional carrer that deals with sick needs legal authorization, legal empowerment with defined eligibility criteria cannot be called a healthCare professional.

2. High-sounding themes, glossy brochures, inaugural lamps, keynote speeches…But without supportive and empowering Act and Rules, they are like screen play.

3. Pharmacy events often speak about clinical excellence, patient-centric care, expanded roles, pharmacovigilance leadership, antimicrobial stewardship, and healthcare innovation. 

- The vision is impressive. The intent is inspiring. Yet, if the legal framework does not clearly authorize, protect, and mandate these roles — the enthusiasm remains confined to conference halls.

4. A profession that deals with medicines and patients cannot grow on motivation and degrees. 

It grows on:

👉 Clear statutory scope of practice 

👉 Defined clinical authority

👉 Mandatory pharmacist presence

👉 Enforceable standards

👉 Protection against encroachment

👉 Accountability backed by law.

Without that, events risk becoming ceremonial rituals

  — intellectual celebrations disconnected from ground reality.

In my own experience as a hospital pharmacist, I know this well: 

👉 Unless the Act empowers the pharmacist to intervene, document, prescribe within scope, or be structurally integrated into care pathways, even the most brilliant clinical discussions remain aspirational.

👉 Professional growth is not built by slogans.

👉 It is built by legislation, enforcement, and institutional will.

Events can ignite thought.

But only strong, supportive rules can institutionalize change.

Otherwise, we are only applauding potential 

— without creating power.😢

#Pharmacist 

#PCI #IPA #AIPDA #APTI

PoV: Bhagwan PS

#Pharmacist - Kaha ka? - Neither for Industry nor for Healthcare, but for Pharmacare - pov: Bhagwaan PS ,modified by: Samrat Paul

#Pharmacist - Kaha ka?

    - Neither for Industry nor for Healthcare, but for Pharmacare

Pharmacists in India face a stark reality: 

There is no exclusivity for them in pharmaceutical industry, R&D, or marketing. Except Diploma Pharmacists graduates and even Clinical Pharmacists with PharmD have no slots to serve in Healthcare

Then, what for these courses are conducted to ruin the life of young aspiring Pharmacists?

 With thousands of colleges producing an overwhelming number of graduates each year, industry is not a viable source of employment.

Shockingly, the IPC which is a conglomeration of IPA, IGPA, APTI, IHPA and PCI has never considered this issue to evolve a solution, inspite of repeatedly voicing the need. 

Irony is IPC wants huge number of Pharmacists from various streams to attend and participate in various activities! but seldom addresses their issues since 1968.

Adding to this crisis are restrictions in our very laws:

Drugs & Cosmetics Act, 1940 does not grant pharmacists exclusive rights in manufacturing, R&D, or marketing; wholesale drug licenses can go to non-pharmacists; even in retail, ownership lies with anyone, with pharmacists reduced to mere signatories. Clinical roles such as counseling or therapy monitoring are not mandated at all.

Pharmacy Act, 1948 is confined largely to registration. Unlike doctors or nurses, pharmacists have no statutory role in patient care. Dispensing is mandatory only on paper—weak enforcement allows rampant proxy practice. Education provisions remain outdated, failing to orient graduates to healthcare needs.

This legal framework leaves them in “Na ghar ka, na ghat ka”—neither industry-recognized nor healthcare-anchored. Yet authorities, academicians, and faculty remain indifferent, even as NAAC delists pharmacy from Health Sciences.

The way forward lies in restructuring. We need intellectually smart teachers to shape smart pharmacists. 

Healthcare is the only sector with infinite potential to absorb all category of Pharmacists —from dispensing to logistics to clinical pharmacy which all together is PharmaCare support to healthCare.

Every hospital unit requires at least one clinical pharmacist and one or two chief pharmacists, besides diploma pharmacists. To make this a reality, pharmacy must be firmly recognized as a Health Science, with education restructured to produce competent professionals.

Since PCI has taken up the task of Updating the B. Pharm Curriculum it should seriously consider to incorporate all activities required to support HealthCare under PharmaCare.

Further, the Profession needs a Supportive laws. Hence, a separate law "#PharmacyPracticeRegulationAct should be legislated that empowers  the Pharmacist with due Accountability. This will eradicate the menace of Certificate renting, Absentee Pharmacist, Corruption arising out of this violation. 

#PCI

#APTI

#IPA

#IPC2025

#Pharmacist 

#Industry 

#Healthcare

POV: Bhagwan PS

A different POV : Pharmacists have failed to impress professionally and leave professional footprints in Healthcare Sector . Pharmacists have failed to impress professionally and leave professional footprints in Healthcare Sector(Pharmacare Sector) OR Physicians have failed to impress professionally and leave professional footprints in Healthcare Sector.

A different POV : Pharmacists have failed to impress professionally and leave professional footprints in Healthcare Sector . Therefore requirement of a new course like Pharm D / Pharma D (PB), which will produce professionals called Pharmacist and Pharmacotherapist. 

Is it true ? Really!!! 

Pharmacists are HealthCare Professionals.

Lets be worth it.

Really!!!,  then why the term ' PharmaCare ' was coined.

Pharmacist A HealthCare professional? If so why pharmacy course is not?. Has the Pharmacy education been got included in National Health Education Manual?

Pharmacists have failed to impress professionally and leave professional footprints in Healthcare Sector 

OR

Physicians have failed to impress professionally and leave professional footprints in Healthcare Sector. 

Traditional Medicine

Traditional medicine encompasses holistic health practices, skills, knowledge, and beliefs from different cultures, using nature-based remedies like herbs, spiritual therapies, and manual techniques to maintain health or treat illnesses, often passed down generations. Key systems include Ayurveda, Traditional Chinese Medicine, and Unani, focusing on restoring balance in mind, body, and environment, with many people in developing nations relying on it for primary care. The World Health Organization supports its safe integration with modern medicine through research and policy

.

 

Key Characteristics

• Holistic Approach: Views health as balance between mind, body, spirit, and environment, not just absence of disease.
• Nature-Based: Relies heavily on plants (herbal medicine), minerals, and animal products.
• Cultural Roots: Deeply embedded in specific cultural histories, passed down through generations.
• Diverse Practices: Includes acupuncture, yoga, meditation, herbal remedies, dietary changes, and spiritual healing. 

Examples of Systems

• Ayurveda (India): Balances the body's three doshas (Vata, Pitta, Kapha) using herbs, diet, and lifestyle.
• Traditional Chinese Medicine (TCM): Uses herbs, acupuncture, and techniques to balance qi (energy).
• Unani (Middle East/India): Based on balancing four humors (blood, phlegm, yellow bile, black bile). 

Modern Context & Integration

• Complementary & Alternative Medicine (CAM): When used alongside or instead of mainstream medicine, it's often called CAM.
• Integration: Efforts, led by the WHO, aim to integrate evidence-based traditional practices with modern medicine for comprehensive care.
• Research: Growing research explores the safety and effectiveness of traditional remedies, like herbs for pain, circulation, and immune support. 

Pharmacy Practice is increasingly labelled as “illegal,” but this argument reflects a policy vacuum rather than a professional failure.

#TalkingIsLegal

     - Not Practicing..!

Pharmacy Practice is increasingly labelled as “illegal,” but this argument reflects a policy vacuum rather than a professional failure.

 The real issue is not the teaching of Pharmacy Practice or PharmaCare, but the absence of a comprehensive legal framework that clearly defines and integrates the pharmacist’s patient-care role within India’s healthcare system.

Healthcare today is medicine-intensive. Polypharmacy, chronic diseases, ageing populations, and medication-related harm are now routine. 

Regulating medicines as products alone is no longer sufficient. Modern healthcare requires PharmaCare-oriented professional practice, where pharmacists are trained and accountable for medication safety, therapy monitoring, patient counselling, continuity of care, and systems-based interventions that directly influence outcomes.

Insisting that the law must evolve before professional capacity is built reverses the natural order of health-system development. 

Across health professions, education has always anticipated emerging roles long before statutes formally recognised them.

Pharmacy Practice and PharmaCare education preparing pharmacists for structured patient-care responsibilities is therefore is legitimate and is necessary and forward-looking.

The confusion arises from India’s fragmented legal framework. The pharmacist’s role is scattered across the Pharmacy Act and the Drugs & Cosmetics Act, with no single statute clearly defining pharmacists as accountable patient-care professionals or formal providers of PharmaCare service within the healthcare team. 

This legal silence enables misinterpretation, under-utilisation of trained pharmacists, and the mistaken branding of structured professional education as “unauthorised practice.”

What India urgently needs is a comprehensive Pharmacy Practice Act that formally recognises and regulates PharmaCare, clearly defining scope, responsibility, accountability, and collaborative boundaries. 

Such legislation would align education with practice, strengthen patient safety, reduce medication-related harm, and integrate pharmacists meaningfully into healthcare delivery.

Suppressing Pharmacy Practice and PharmaCare education will not improve safety; it will only widen the gap between healthcare needs and system capacity. 

The real policy question is not why these competencies are being taught, but why regulation has not  yet been put in place to keep  pace with the realities of modern healthcare.?

#PharmacyPractice 

#PharmaCare #PharmacyPracticeAct

#PatientSafety #MedicationSafety

#HealthcarePolicy #HealthPolicyIndia

#PharmacyEducation #ClinicalPharmacy

#AIPDA

#APTI

#PharmacistsInHealthcare

#PCI #NMC #CDSCO #DTAB #MinistryOfHealth

Pov: Bhagwan PS

#Can Pharmacy Practice Be A Reality In India?

#CanPharmacyPracticeBeARealityInIndia?

Let’s be honest about Pharmacy Practice in India.

🤔 Pharmacy Practice Regulations (PPR) 2015–25 are repeatedly cited as proof that pharmacy practice is legally recognized in India. 

❌In reality, that claim does not stand up to scrutiny. PPR 2015–25 were framed by the Pharmacy Council of India under the Pharmacy Act, 1948 to hoodwink PharmD students and Graduates.

☑️But the Pharmacy Act primarily governs education and registration. 

❌It does not confer enforceable patient-care authority, nor does it empower PCI to regulate clinical practice on the ground. 

❌Calling PPR a “regulation” does not automatically make it enforceable.

☑️On the field, real power lies with State Drug Control Departments under the Drugs and Cosmetics Act. 

☑️Licensing, inspections, prosecutions, and control over dispensing are all under FDA jurisdiction. 

❌PPR provisions are not embedded in State Drug Rules, and therefore remain legally optional.

❌FDAs are not bound to enforce what the law does not mandate.

☑️That is why pharmacy practice in India exists only in pockets. 

☑️A few hospitals run clinical pharmacy services because administrators allow it not the system.

☑️A few pharmacists counsel patients because they personally believe in it.

❌This is not system-driven practice;

 It is goodwill-driven survival.

☑️ The uncomfortable truth is this: 

• PPR 2015–25 is not legally tenable as an enforcement instrument. 

• It creates expectations without authority and 

(Like Alcohol, It creates desire but takes away performance..)

• It assigns responsibility without power. 

Worse,

• It gives the illusion of progress while shielding regulators from accountability for not securing supportive legislation.

👉 If pharmacy practice is truly the goal, then guidelines are not enough. 

👉 The profession needs statutory backing—A comprehensive

 "The Indian Pharmacy Practice Regulation Act".

👉 Fresh Rules have to be framed after the Act is put in place.

❌ Without that, PPR remains a document of intent, not law.

😢 Continuing to celebrate PPR while ignoring its legal weakness is intellectual dishonesty. (Bankruptcy) 

📢Pharmacy practice will not be built on aspirations, circulars, or seminars, Webinars of so called Resource Persons. 

👉It will be built only when law, administration, and accountability are aligned.

Till then, let’s stop pretending.🫢

#PCI, #PPR15-25,

#MinistryofHealthandFamilyWelfare 

#AIPDA 

#PharmD 

#APTI

POV: Bhagwan PS

Pharmacy Practice is increasingly labelled as “illegal,” but this argument reflects a policy vacuum rather than a professional failure.

#TalkingIsLegal

     - Not Practicing..!

Pharmacy Practice is increasingly labelled as “illegal,” but this argument reflects a policy vacuum rather than a professional failure.

 The real issue is not the teaching of Pharmacy Practice or PharmaCare, but the absence of a comprehensive legal framework that clearly defines and integrates the pharmacist’s patient-care role within India’s healthcare system.

Healthcare today is medicine-intensive. Polypharmacy, chronic diseases, ageing populations, and medication-related harm are now routine. 

Regulating medicines as products alone is no longer sufficient. Modern healthcare requires PharmaCare-oriented professional practice, where pharmacists are trained and accountable for medication safety, therapy monitoring, patient counselling, continuity of care, and systems-based interventions that directly influence outcomes.

Insisting that the law must evolve before professional capacity is built reverses the natural order of health-system development. 

Across health professions, education has always anticipated emerging roles long before statutes formally recognised them.

Pharmacy Practice and PharmaCare education preparing pharmacists for structured patient-care responsibilities is therefore is legitimate and is necessary and forward-looking.

The confusion arises from India’s fragmented legal framework. The pharmacist’s role is scattered across the Pharmacy Act and the Drugs & Cosmetics Act, with no single statute clearly defining pharmacists as accountable patient-care professionals or formal providers of PharmaCare service within the healthcare team. 

This legal silence enables misinterpretation, under-utilisation of trained pharmacists, and the mistaken branding of structured professional education as “unauthorised practice.”

What India urgently needs is a comprehensive Pharmacy Practice Act that formally recognises and regulates PharmaCare, clearly defining scope, responsibility, accountability, and collaborative boundaries. 

Such legislation would align education with practice, strengthen patient safety, reduce medication-related harm, and integrate pharmacists meaningfully into healthcare delivery.

Suppressing Pharmacy Practice and PharmaCare education will not improve safety; it will only widen the gap between healthcare needs and system capacity. 

The real policy question is not why these competencies are being taught, but why regulation has not  yet been put in place to keep  pace with the realities of modern healthcare.?

#PharmacyPractice 

#PharmaCare #PharmacyPracticeAct

#PatientSafety #MedicationSafety

#HealthcarePolicy #HealthPolicyIndia

#PharmacyEducation #ClinicalPharmacy

#AIPDA

#APTI

#PharmacistsInHealthcare

#PCI #NMC #CDSCO #DTAB #MinistryOfHealth

Pov: Bhagwan PS

10 CORE QUESTIONS TO PHARMACY LEADERS & REGULATORS (1948–2025)- Bhagwan PS

10 CORE QUESTIONS TO PHARMACY LEADERS & REGULATORS (1948–2025)

1. Why has the Pharmacy Act, 1948 failed to legally define, protect, and enforce Pharmacy Practice, leaving pharmacists without statutory professional authority even after 75+ years?

2. How and why did pharmacy regulation become academically dominated, excluding practicing pharmacists, healthcare administrators, and industry professionals, and what damage did this regulatory capture cause?

3. On what rationale were thousands of pharmacy colleges approved without ensuring employability, practice roles, or healthcare integration for graduates?

4. Why were chronic inspection malpractices (ghost faculty, fake infrastructure, borrowed facilities) tolerated or normalized, and who is accountable for this systemic fraud?

5. Why has no regulator or professional body been held personally or institutionally accountable for repeated failures in education quality, professional outcomes, and patient safety?

6. Why were clinical pharmacy, PharmD, and advanced programs introduced without corresponding legal authority to practice, thereby misleading students and families?

7. Why has pharmacist presence at dispensing points, hospitals, and public health programs not been strictly enforced, despite clear patient-safety implications?

8. Why have professional associations largely remained silent or complicit, prioritizing events and positions over legal reform and whistleblower protection?

9. How has the absence of a Pharmacy Practice law contributed to public-health failures, including medication errors, irrational drug use, and antibiotic resistance?

10. Do you accept the need for a complete structural reset—including a separate Pharmacy Practice & Education Regulation Act, reconstitution of the regulator, and criminal accountability for past educational fraud?

#PCI #MoHFW, #ÇDSCO, 

#IPA, #IHPA, #APTI, 

#Pharmacists 

#Exofficios

Pharmacy Intern and Resident

Pharmacy Intern is a student (PharmD candidate) gaining required experience under supervision, while a Pharmacy Resident is a post-graduate pharmacist (a licensed professional) pursuing advanced, specialized training after graduation, both roles involving patient care but at different educational and licensure stages, with residency being optional and enhancing specialized career paths. Interns work towards their degree, performing basic pharmacist duties with a license, whereas Residents, fully licensed, deepen expertise in areas like critical care, oncology, or administration through structured programs (PGY-1, PGY-2). 

Pharmacy Intern

• Status: A pharmacy student (PharmD candidate) completing required experiential rotations.
• Timing: During their degree program, often the final year.
• Role: Assists licensed pharmacists, performs patient counseling, assessments, and dispensing under direct supervision, often with an intern license.
• Goal: Fulfill graduation requirements and gain foundational practice skills. 

Pharmacy Resident

• Status: A fully licensed pharmacist who has graduated from pharmacy school.
• Timing: After graduation (Post-Graduate Year 1, or PGY-1) and potentially further (PGY-2 for specialization).
• Role: Advanced, independent (but supervised) patient care, research, education, and specialized rotations (e.g., critical care, infectious diseases).
• Goal: Develop expertise in a specific clinical area or management, gaining a competitive edge for specialized roles. 

Key Differences Summarized

• Education Level: Student vs. Graduate.
• Licensure: Intern license vs. Full pharmacist license.
• Purpose: Required training vs. Optional specialization.
• Scope: Foundational duties vs. Advanced clinical practice & research. 

Medical Intern and Resident

An intern is a medical school graduate in their first year of post-graduate training, often called a "first-year resident" in the U.S.. A resident is a doctor in their second year or any subsequent year of post-graduate training after the internship, specializing in a specific area. The primary difference is the level of training and experience; an intern is at the beginning, while a resident is further along, taking on more responsibility and working towards board certification in a specialty.  

Feature	Intern	Resident
Level of Training	First year of postgraduate medical training	Years 2+ of postgraduate training
Autonomy	Works under close supervision and guidance	Takes on more responsibility and supervises interns and medical students
Specialization	General training to be licensed to practice	Specializing in a particular medical field
Experience	New to clinical practice after medical school	Has completed the initial internship year
Role	Completes tasks under direction	Manages patient care, diagnoses, and treatment plans

No, there is no equivalent of "deemed boards" for schools in the way there are "deemed-to-be-universities" for higher education in India.

No, there is no equivalent of "deemed boards" for schools in the way there are "deemed-to-be-universities" for higher education in India. 

The concept of "deemed to be university" is a specific accreditation status granted to a higher educational institution (like a college) by the University Grants Commission (UGC) and the Ministry of Education, allowing it autonomy in setting its own syllabus, conducting examinations, and awarding degrees. 

School education is structured differently: 

• Governing Bodies: Schools are affiliated with a number of recognized boards. These are established by either the central government or state governments and have the authority to prescribe curricula and conduct examinations for classes 10 and 12.
• Central Boards: The primary national boards are the Central Board of Secondary Education (CBSE), the Council for the Indian School Certificate Examinations (CISCE), and the National Institute of Open Schooling (NIOS).
• State Boards: Each state has its own board of education (e.g., Board of Secondary Education Rajasthan) that governs the schools within that state.
• International Boards: Some schools also offer international curricula like the International Baccalaureate (IB) or Cambridge Assessment International Education (CAIE). 

All these boards operate under the oversight of government bodies and are part of a recognized system of school education. The status of "deemed" with the autonomy it implies for higher education institutions does not apply to school boards. 

USA :

That is correct; there is no direct equivalent of "deemed boards" for high schools in the United States in the way the "deemed-to-be-universities" concept functions in the Indian higher education system. 

Here's why:

• Decentralized System: The U.S. does not have a centralized national education system or a federal body that grants a special "deemed" status to school boards. Educational standards and recognition are primarily set at the state and local levels.
• Accreditation Model: Instead of a "deemed" status granted by a central government ministry (like in India for universities), U.S. high schools rely on a system of accreditation by independent, private, regional, or national agencies recognized by the Department of Education. This accreditation process assures a certain level of educational quality and ensures that diplomas are widely recognized by other institutions and employers.
• State-Level Recognition: State departments of education oversee public high schools and ensure they meet state-mandated requirements. A diploma from a state-recognized public high school is generally considered valid and standard.
• Private School Oversight: Private high schools also exist and typically seek accreditation from one of the recognized accrediting bodies to validate their educational programs. 

In essence, the U.S. system uses the general concept of accreditation to establish educational legitimacy across the board, rather than a specific "deemed" status for select, high-performing boards or institutions in K-12 education.

Parapharmacy

A parapharmacy is a retail store that sells non-medicinal health, hygiene, and beauty products, such as cosmetics, skincare, vitamins, and baby care items. These stores offer products that do not require a medical prescription and are distinct from traditional pharmacies, which are authorized to sell and dispense prescription and over-the-counter medications. 

Key characteristics:

Product range: Parapharmacies focus on products that support health and wellness without a prescription. This includes a wide selection of items related to beauty, skincare, hair care, sun care, and dietary supplements.

• Accessibility: They are often conveniently located, providing easy access for consumers.
• No prescription required: Unlike a traditional pharmacy, a parapharmacy does not sell or dispense prescription drugs.
• Guidance: Staff are often knowledgeable about the products they sell and can provide advice on their use and benefits.
• Business model: In some countries, like France, parapharmacies have grown as specialized retailers offering a wider choice than traditional pharmacies, sometimes managed by pharmacists who offer free skincare advice. 

Say No to DRx , use Pharmacist

DRx can have different meanings depending on the context, most commonly referring to "Drug Expert," a prefix used by some pharmacists in India to signify their professional expertise. 

As "Drug Expert" (Pharmacists) 

         Meaning: 

• The full form is DRug eXpert.   
• Purpose: 
• It is used by pharmacists to indicate their knowledge and expertise in medications and drug therapy, as well as their licensed and registered status. 
• Usage: 
• This is an informal prefix and not officially recognized by the Pharmacy Council of India, although it is gaining traction among pharmacists, especially in India. It is not the same as the "Dr." title for medical doctors. 
• 
  
• Eligibility: 
• Those who have completed professional pharmacy courses like B.Pharm and M.Pharm can use the title. 

don't rent your pharmacy license

Difference Between PCD(Propaganda Cum Distribution)(Standard) , Generic, and Ethical Pharma Sectors

Difference Between PCD, Generic, and Ethical Pharma Sectors

Difference between PCD, Generic, and Ethical Pharma Sectors? – The pharmaceutical industry is quite large. There are a lot of small enterprises and sectors inside it, which are in major focus. Across all sectors, Pharma Franchise and PCD Pharma Franchise are prominent. 

Simultaneously, the pharmaceutical industry is directly linked with the nation’s economic growth, which is an extra factor that boosts the popularity of the pharmaceutical business sector.

Difference Between PCD, Generic, and Ethical Pharma Sectors

It is necessary to distinguish between PCD, generic, and ethical pharma sectors. There is a wide difference between the three here.

1. PCD (Propaganda- Cum- Distribution)

PCD stands for propaganda-less distribution means a type of sector in which a pharma company contracts a franchise agreement with a person or group of people.

The PCD franchise business deals with marketing and distribution rights for products by the parent pharma company.

Under the PCD model, the entrepreneur is required to purchase the franchise rights of a pharma company and start selling their products. They usually interact to physicians and doctors to promote the company’s products.

A person, who wants to start a firm in this field, needs to invest a lesser amount. In addition, marketing and promotional costs will also be provided by the pharma company only.

2. Generic Sector

In this generic pharma sector, generic drugs are manufactured by a pharma company and sold directly to retailers with distribution channels and sales representatives support.

Generic medicines use a similar administration route and simultaneously display the brand name of the products. In addition, they have similar quality and performance levels. 

The advantage of being in the generic sector is that generic medicines are priced lower than branded drugs. It is an economically effective and efficient business.

Sometimes the making process can also change, which affects the cost of the drug. The cost of generic medicines is held much lower than that of branded medicines.

3. Ethical Pharma Sector

Ethical pharma is the traditional and most popular part of the pharma industry. Here, all types of medicinal medicines are spread through medical representatives.

Medical representatives share all necessary information with doctors. They aim to convince doctors about the merits of the products over others.

There are many marketing techniques and methods used with the doctor to promote a specific drug range.

Conclusion: 

PCD, generic, and ethical pharma are all three different types of business practices. However, the general point is that they all belong to the pharma family and have different distribution channels